Intravenous anesthetic, propofol inhibits invasion of cancer cells

Mammoto, Tadanori; Mukai, Mutsuko; Mammoto, Akiko; Yamanaka, Yasutsugu; Hayashi, Yukio; Mashimo, Takashi; Kishi, Yoshihiko; Nakamura, Hiroyuki

doi:10.1016/s0304-3835(02)00210-0

Cited by 139 publications

(98 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our results were consistent with those of other studies. For example, Mammoto et al (2002) demonstrated that propofol decreased the invasion ability of human cancer cells (HeLa, HT1080, HOS, and RPMI-7951). Miao et al (2010) reported that propofol inhibited invasion of LOVO colon cancer cells.…”

Section: Discussionmentioning

confidence: 99%

“…Recently, increasing evidence indicates a possible correlation between propofol and cancers. Propofol has the ability to inhibit the adhesion, proliferation, and invasion, and induce apoptosis of cancer cells (Mammoto et al, 2002;Miao et al, 2010;Altenburg et al, 2011;Zhang et al, 2013b). Therefore, propofol might be a better agent than other anesthetics for cancer surgery (Inada et al, 2011).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Propofol suppresses proliferation and invasion of gastric cancer cells via downregulation of microRNA-221 expression

Zt¹,

Hy²,

Fang³

et al. 2015

Genet. Mol. Res.

View full text Add to dashboard Cite

ABSTRACT. Propofol is one of the extensively and commonly used intravenous anesthetic agents. The current study aimed to evaluate the effects of propofol on the behavior of human gastric cancer cells and the molecular mechanisms of this activity. The effects of propofol on SGC7901 and AGS cell proliferation, apoptosis, and invasion were detected by MTT assay, flow cytometric analysis, and matrigel invasion assay. Real-time polymerase chain reaction (PCR) was used to assess microRNA (miR)-221 expression. miR-221 mimics were transfected into SGC7901 and AGS cells to assess the role of miR-221 in propofol-induced anti-tumor activity. Propofol significantly inhibited cell proliferation and invasion and promoted apoptosis of SGC7901 and AGS cells. Propofol also efficiently reduced miR-221 expression. Moreover, transfection of miR-221 mimics reversed the effects of propofol on the biological behavior of gastric cancer cells. Propofol can effectively inhibit proliferation and invasion and induce apoptosis of gastric cancer cells through, at least partly, downregulation of miR-221 expression.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Propofol suppresses proliferation and invasion of gastric cancer cells via downregulation of microRNA-221 expression

Zt¹,

Hy²,

Fang³

et al. 2015

Genet. Mol. Res.

View full text Add to dashboard Cite

show abstract

“…Increasing evidence has shown that propofol can effectively modulate the behavior of numerous human cancer cell types in vitro and in vivo (8)(9)(10). For example, propofol can effectively inhibit cell proliferation and invasion of cervical cancer, pancreatic cancer (11), gastric cancer (12) and colon carcinoma (10).…”

Section: Discussionmentioning

confidence: 99%

“…Previous studies have confirmed that propofol also has an antitumor effect (8)(9)(10)(11)(12). Clinically relevant concentrations of propofol have the ability to inhibit cell proliferation, motility and invasion, and induce apoptosis of many cancer cells, such as HeLa, HT1080, HOS and RPMI-7951 (9).…”

Section: Introductionmentioning

confidence: 95%

Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway

Zou

et al. 2017

Experimental and Therapeutic Medicine

View full text Add to dashboard Cite

Abstract. Propofol is a commonly used intravenous anesthetic in tumor surgery. Recently, studies have confirmed that propofol has an antitumor effect on hepatocellular carcinoma (HCC); however, the molecular mechanism underlying this effect has not been elucidated until now. The present study aimed to investigate the mechanism of propofol on HepG2 cell proliferation, apoptosis and invasion, focusing on High Mobility Group AT-Hook 2 (HMGA2)-mediated Wnt/β-catenin pathway. The HepG2 cells were treated with various concentrations of propofol for 24 h, the relative protein levels of HMGA2, Wnt3a, β-catenin, Snail Family Zinc Finger 1 and c-myc were determined by western blot analysis. HMGA2-pcDNA3.1 plasmid was transfected into the HepG2 cells to overexpress HMGA2. Cell proliferation, apoptosis and invasion were examined by MTT assays, flow cytometry and Transwell-matrigel invasion assays, respectively. The results showed that propofol suppressed HMGA2 expression and Wnt/β-catenin signaling in a dose-dependent manner. Propofol was able to inhibit cell proliferation and invasion, and induce cell apoptosis of HepG2 cells; however, these effects were attenuated by HMGA2 overexpression. The suppressed Wnt/β-catenin signaling in HepG2 cells by treatment with propofol was also reversed by HMGA2 overexpression. In conclusion, this study provided a novel mechanism underlying the anti-tumor function of propofol on HCC. To the best of our knowledge, the present study is the first to demonstrate that propofol could downregulate the expression of HMGA2, which inhibited the Wnt/β-catenin pathway, thus leading to the inhibition of cell proliferation and invasion, as well as the apoptosis of HepG2 cells.

show abstract

“…5 In contrast, propofol is variously reported to be inhibitory, 6 have little effect, 7 or even enhance immune function. 8 Opioid analgesics inhibit both cellular and humoral immune function in humans. 9,10 Furthermore, morphine is pro-angiogenic and promotes breast tumour growth in rodents.…”

Section: Résumémentioning

confidence: 99%

Thoracic paravertebral regional anesthesia improves analgesia after breast cancer surgery: a randomized controlled multicentre clinical trial

Buggy

Fleischmann

et al. 2014

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

Background The contribution of regional anesthesia with thoracic paravertebral blockade to postoperative analgesia remains unclear. We compared the effect of a combination of paravertebral blockade and propofol general anesthesia (GA) with sevoflurane GA and opioid analgesia on postoperative pain and opioid use for patients undergoing breast cancer surgery. Methods Patients having breast cancer surgery were randomly assigned to paravertebral analgesia with propofol GA (PPA, n = 187) or sevoflurane GA with perioperative opioid analgesia (SOA, n = 199). The PPA and SOA groups were compared for opioid consumption and pain outcomes (on a 0-10 visual analogue scale [VAS]) at two hours postoperatively using superiority and inferiority statistics. We compared our results with previous publications in a meta-analysis. [0,12] mg, respectively, morphine equivalents; median difference -3; 99% CI: -4 to -2). Thus, non-inferiority was detected for all the above outcomes, and superiority tests for each outcome were highly significant in the expected directions (P \ 0.001). Meta-analysis, including the current study, estimated a reduction in worst pain of 2.3 points (95% CI: 1.8 to 2.8) on a 0-10 scale and a 72% reduction (95% CI: 42 to 87) in Conclusion Nos résultats ont été largement concordants avec des études antérieures beaucoup plus petites. Comparativement à l'AG au sévoflurane avec analgésie par opioïdes, l'association d'une analgésie paravertébrale et d'une AG au propofol a fourni des avantages cliniques précoces pour les femmes subissant une chirurgie pour cancer du sein. Cette analyse est une sous-étude d'un essai randomisé multicentrique à double insu sur la récidive cancéreuse (www.ClinicalTrials.gov: n8 NCT00418457).

show abstract

Intravenous anesthetic, propofol inhibits invasion of cancer cells

Cited by 139 publications

References 12 publications

Propofol suppresses proliferation and invasion of gastric cancer cells via downregulation of microRNA-221 expression

Propofol suppresses proliferation and invasion of gastric cancer cells via downregulation of microRNA-221 expression

Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway

Thoracic paravertebral regional anesthesia improves analgesia after breast cancer surgery: a randomized controlled multicentre clinical trial

Contact Info

Product

Resources

About